2-氨基-3,6-二甲基苯甲酸 | 15540-91-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-3,6-二甲基苯甲酸
• 英文名称: 2-amino-3,6-dimethylbenzoic acid
• 英文别名: 3,6-dimethyl-2-aminobenzoic acid；3,6-Dimethylanthranilic Acid；3,6-dimethylanthranylic acid；3,6-dimethylanthranlic acid；2-amino-3,6-dimethyl-benzoic acid；2-Amino-3,6-dimethyl-benzoesaeure
• CAS: 15540-91-7
• 化学式: C₉H₁₁NO₂
• 分子量: 165.192
• InChiKey: PFKMPZBEUUAELA-UHFFFAOYSA-N

物化性质

• 熔点：
  111-113 °C (decomp)
• 沸点：
  319.8±30.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990

反应信息

• 作为反应物：
  描述：

  2-氨基-3,6-二甲基苯甲酸 生成 2,5-二甲基苯甲酸
  参考文献：
  名称：

  Predictions of strontium accommodation in A₂B₂O₇ pyrochlores

  摘要：

  A2B2O7 烧绿石氧化物被认为是固定裂变产物的潜在宿主材料。因此，确定这些化合物容纳裂变产物离子的相对能力非常重要。为了解决这个问题，我们使用计算机模拟来预测与 Sr2+ 溶液相关的结构和相对平衡能量，其组成范围很广。结果表明，锶是通过氧空位补偿来替代 A 主阳离子的。这导致了一种非化学计量成分。通过构建等值线能量图，确定了最佳成分和缺陷簇结构。

  DOI：

  10.1557/jmr.2002.0302
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 sodium hydroxide 、 双氧水 作用下， 生成 2-氨基-3,6-二甲基苯甲酸
  参考文献：
  名称：

  Mayer; Schaefer; Rosenbach, Archiv der Pharmazie, 1929, p. 583

  摘要：

  DOI：

文献信息

• [EN] TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION EN TANT QUE PESTICIDES
  申请人：SUMITOMO CHEMICAL CO

  公开号：WO2013162072A1

  公开（公告）日：2013-10-31

  The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, or a C3-C12 cycloalkyl group, etc., which each optionally be substituted; R2, R3, R4 and R5 represent independently of each other a hydrogen atom, a halogen atom or an C1-C3 alkyl group, etc.; R6 represents an C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom, a C1-C6 haloalkyl group, an C2-C6 alkenyl group, an C1-C6 alkoxy group, or a C1-C6 haloalkoxy group, etc.; R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, or an C1-C4 alkyl group, etc.; X represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.

  本发明提供了一种具有优异杀虫效果的化合物。公式（1）的四唑酮化合物：[其中R1代表C6-C16芳基、C1-C12烷基或C3-C12环烷基等，每个都可以选择性地被取代；R2、R3、R4和R5分别独立地代表氢原子、卤素原子或C1-C3烷基等；R6代表C1-C6烷基、C3-C6环烷基、卤素原子、C1-C6卤代烷基、C2-C6烯基、C1-C6烷氧基或C1-C6卤代烷氧基等；R7、R8和R9分别独立地代表氢原子、卤素原子或C1-C4烷基等；X代表氧原子或硫原子；R10代表C1-C6烷基等]在杀虫方面表现出优异的控制效果。
• [EN] COMPOUNDS AND COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSÉS ET COMPOSITIONS, ET UTILISATIONS ASSOCIÉES
  申请人：SUNOVION PHARMACEUTICALS INC

  公开号：WO2018023070A1

  公开（公告）日：2018-02-01

  Compounds of formula (I) are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need thereof are also disclosed.

  公式（I）的化合物已被披露，还披露了含有这些化合物的药物组合物。还披露了治疗需要的主体神经系统或精神疾病和障碍的方法。
• Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix
  申请人：American Cyanamid Company

  公开号：US05929097A1

  公开（公告）日：1999-07-27

  The present invention relates to the discovery of novel, low molecular weight, non-peptide inhibitors of matrix metalloproteinases (e.g. gelatinases, stromelysins and collagenases) and TNF-.alpha. converting enzyme (TACE, tumor necrosis factor-.alpha. converting enzyme) which are useful for the treatment of diseases in which these enzymes are implicated such as arthritis, tumor growth and metastasis, angiogenesis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, proteinuria, aneurysmal aortic disease, degenerative cartilage loss following traumatic joint injury, demyelinating diseases of the nervous system, graft rejection, cachexia, anorexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease, HIV infection, age related macular degeneration, diabetic retinopathy, proliferative vitreoretinopathy, retinopathy of prematurity, ocular inflammation, keratoconus, Sjogren's syndrome, myopia, ocular tumors, ocular angiogenesis/neovascularization. The TACE and MMP inhibiting ortho-sulfonamido aryl hydroxamic acids of the present invention are represented by the formula ##STR1## where the hydroxamic acid moiety and the sulfonamido moiety are bonded to adjacent carbons on group A.

  本发明涉及新发现的低分子量、非肽类基质金属蛋白酶（例如明胶酶、溶基质素和胶原酶）和肿瘤坏死因子α转化酶（TACE，肿瘤坏死因子α转化酶）的抑制剂，这些抑制剂用于治疗与这些酶相关的疾病，如关节炎、肿瘤生长和转移、血管生成、组织溃疡、异常伤口愈合、牙周病、骨病、蛋白尿、动脉瘤性主动脉疾病、关节创伤后的退行性软骨损失、神经系统脱髓鞘疾病、移植物排斥、恶病质、厌食、炎症、发热、胰岛素抵抗、感染性休克、充血性心力衰竭、中枢神经系统炎症性疾病、炎症性肠病、HIV感染、与年龄相关的黄斑变性、糖尿病视网膜病变、增生性玻璃体视网膜病变、早产儿视网膜病变、眼内炎症、圆锥角膜、干燥综合症、近视、眼内肿瘤、眼内血管生成/新生血管。本发明的TACE和MMP抑制的邻磺酰胺基芳基羟肟酸由下式表示：##STR1##，其中羟肟酸基团和磺酰胺基团通过相邻的碳原子与A组连接。
• Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastase
  作者：Allen Krantz、Robin W. Spencer、Tim F. Tam、Teng Jiam Liak、Leslie J. Copp、Everton M. Thomas、Steven P. Rafferty

  DOI：10.1021/jm00164a002

  日期：1990.2

  inhibitors of the serine proteinase human leukocyte elastase (HL elastase) and form acyl enzyme intermediates during enzyme catalysis. We have synthesized a large variety of benzoxazinones using specific methods that have been adapted to achieve the pattern of ring substitution dictated by theoretical considerations. The results of the inhibition of HL elastase by 175 benzoxazinones are reported herein

  4H-3,1-Benzoxazin-4-ones是丝氨酸蛋白酶人类白细胞弹性蛋白酶（HL弹性蛋白酶）的替代底物抑制剂，在酶催化过程中形成酰基酶中间体。我们已经使用特定方法合成了多种苯并恶嗪酮，这些特定方法已被调整以实现理论上的考虑而决定的环取代方式。本文参考疏水常数D，碱水解速率kOH-，抑制常数Ki及其组分酰化和脱酰化速率常数kon和koff分别报道了175种苯并恶嗪酮对HL弹性蛋白酶的抑制结果。化合物的范围是可观的。碱水解速率和kon跨度为6，koff覆盖5，ki跨度为8个数量级。在这个大数据集上的多元回归已被用于隔离电子和空间效应以及化合物稳定性和弹性蛋白酶抑制特异的其他因素的作用。本质上，简单的电子参数足以说明碱性水解数据中几乎所有的变化，表明电子因素是此类苯并嗪酮反应性的主要决定因素。显着增强苯并恶嗪酮I效力的因素是R5烷基和R2撤离电子。R 7和R 8中的体积大和化合物疏水性不显着，但是R
• Electroorganic reactions. Part 55.† Quinodimethane chemistry. Part 3. Transition metal complexes as inter- and intra-molecular redox catalysts for the electrosynthesis of poly(p-xylylene) (PPX) polymers and oligomers‡
  作者：Robert G. Janssen、James H. P. Utley、Emmanuelle Carré、Evelyne Simon、Heike Schirmer

  DOI：10.1039/b103274g

  日期：——

  The role of metal complexes as redox mediators in the electrosynthesis of poly(p-xylylenes) (PPXs) has been explored, with a view to designing metal-containing precursors that can act both as mediators and starting materials for metal-containing polymers. A number of transition metal complexes [Cr(III), Ni(II) and Co(II)] are efficient redox catalysts for production of quinodimethanes, and hence PPXs. Following encouraging results from experiments using mediators based on anthranilic acid and salicylaldehyde ligands a macrocyclic compound was designed, and successfully prepared by a convergent route that incorporated both a 1,4-bis(chloromethylarene) function as a precursor to a quinodimethane and a Ni(II) salen unit as an intramolecular redox catalyst. The macrocycle was successfully reduced cathodically to yield a PPX polymer with bound Ni(II). Evidence is presented for the operation of intramolecular redox catalysis (homomediation).

  金属配合物在聚对苯二甲基酚（PPXs）的电合成中作为氧化还原介质的作用得到了研究，目的是设计出既能作为介质又能作为金属含聚合物的起始材料的金属含前体。一些过渡金属配合物[Cr(III)、Ni(II)和Co(II)]是生产 quinodimethanes 及因此 PPXs 的有效氧化还原催化剂。在使用基于邻氨基苯酸和水杨醛配体的介质进行实验后取得了令人鼓舞的结果，设计并成功合成了一种宏环化合物，该合成采用了汇聚方法，其中包含了 1,4-双(氯甲基芳烃)作为 quinodimethane 的前体和 Ni(II) salen 单元作为分子内氧化还原催化剂。该宏环成功通过阴极还原得到了一种与 Ni(II) 结合的 PPX 聚合物。提供了分子内氧化还原催化（同调介导）作用的证据。